# Ethan Basch

Source: https://onco.cc/people/ethan-basch/  
OnCo record `ethan-basch` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Proved that letting patients report symptoms electronically during chemotherapy improves quality of life and survival.

## Summary

Ethan Basch led the randomised trial showing that systematic electronic patient-reported symptom monitoring during chemotherapy improves quality of life, reduces emergency visits and extends overall survival, and the national PRO-TECT trial confirming it in community practices. He developed the PRO-CTCAE toxicity instrument with the NCI and has shaped FDA and ASCO policy on patient-reported outcomes.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: supportive-care; patient-reported-outcomes; outcomes
- Role: Chief of Medical Oncology and Physician-in-Chief, UNC Lineberger Comprehensive Cancer Center
- Specialisms: Patient-reported outcomes; Symptom monitoring; Health outcomes research; Trial methodology

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Basch%20E%5BAuthor%5D%20patient-reported%20outcomes

## Connected records

- institutions: [UNC Lineberger Comprehensive Cancer Center](https://onco.cc/institutions/unc-lineberger/)
- key papers: [Basch: asking patients to report symptoms online during chemotherapy improved survival](https://onco.cc/key-papers/paper-basch-epro-survival-jama-2017/)

---
JSON: https://onco.cc/api/v1/entities/ethan-basch.json